Eli Lilly (LLY) Minority Interest (2009 - 2025)

Eli Lilly (LLY) has 17 years of Minority Interest data on file, last reported at $57.5 million in Q3 2025.

• For the quarter ending Q3 2025, Minority Interest fell 28.75% year-over-year to $57.5 million; the trailing twelve-month figure through Sep 2025 stood at $57.5 million (down 28.75% YoY), and the FY2024 full-year result was $79.5 million, down 13.4% from the prior year.
• Minority Interest for Q3 2025 stood at $57.5 million, down from $76.2 million in the prior quarter.
• Across five years, Minority Interest topped out at $219.1 million in Q2 2021 and bottomed at $57.5 million in Q3 2025.
• The 5-year median for Minority Interest is $91.8 million (2023), against an average of $113.8 million.
• The widest annual swing landed in 2021, when Minority Interest jumped 69.43%; it then tumbled 51.4% in 2022.
• A 5-year view of Minority Interest shows it stood at $175.6 million in 2021, then retreated by 28.47% to $125.6 million in 2022, then slipped by 26.91% to $91.8 million in 2023, then decreased by 13.4% to $79.5 million in 2024, then dropped by 27.67% to $57.5 million in 2025.
• The last three Minority Interest figures came in at $57.5 million (Q3 2025), $76.2 million (Q2 2025), and $82.0 million (Q1 2025), per Business Quant data.

Peer Comparison